Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid™ ...

Isabel Newton, MD, PhD, has been named Chief Medical Officer of Boston Scientific's Interventional Oncology and Embolizatio ...

HOUSTON -- Preoperative embolization of meningioma was associated with improved relapse-free survival (RFS) in a retrospective propensity-matched review. Surgery without embolization was associated ...

Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, today ...

Hemorrhagic cystitis (HC) is a frequent and sometimes life-threatening complication after hematopoietic SCT (HSCT). Many therapeutic approaches have been performed to control HC, but their effect is ...

Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced the completion of the ...

PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...

The treatment of a subdural hematoma received a major boost with three new randomized controlled trials all showing large and significant benefits of a new embolization process done as an endovascular ...

First lady Melania Trump is recovering from an embolization procedure that she underwent Monday to treat a benign kidney condition, the White House announced — just minutes after word of former Sen.

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid liquid embolic agent. Squid is approved ...